Upcoming Meetings: FDA Anesthesiology and Respiratory Therapy Devices Panel
This article was originally published in The Gray Sheet
Executive Summary
FDA Anesthesiology and Respiratory Therapy Devices Panel: Slated to meet Nov. 22 at FDA's Corporate Building in Rockville, Maryland to consider a petition for reclassification from Class III to Class II of a nitric oxide administration system. For more information, contact FDA's Michael Bazaral at 301/443-8609...